Fundraising Fox

Parabilis Medicines

4 known investors

parabilismed.com ↗

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules. The platform uses AI and simulation to engineer helical peptides with non-canonical amino acids for precision binding across a range of therapeutic applications.

AI & Machine LearningBiotechDeep TechMedical Devices

Founders & leadership

MM
Mathai MammenCEO, President and Chairman

Investors · 4

ARCH Venture PartnersChicago
Nextech InvestZurich
venBio PartnersSan Francisco
Frazier Life SciencesreportedPalo Alto

In the news